- Home
- IMVT vs BANC Comparison
IMVT vs BANC Comparison
Compare IMVT & BANC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMVT
- BANC
- Stock Information
- Founded
- IMVT 2018
- BANC 1941
- Country
- IMVT United States
- BANC United States
- Employees
- IMVT N/A
- BANC 1903
- Industry
- IMVT Biotechnology: Biological Products (No Diagnostic Substances)
- BANC Major Banks
- Sector
- IMVT Health Care
- BANC Finance
- Exchange
- IMVT Nasdaq
- BANC Nasdaq
- Market Cap
- IMVT 2.7B
- BANC 2.3B
- IPO Year
- IMVT N/A
- BANC N/A
- Fundamental
- Price
- IMVT $16.08
- BANC $14.53
- Analyst Decision
- IMVT Buy
- BANC Buy
- Analyst Count
- IMVT 11
- BANC 11
- Target Price
- IMVT $37.38
- BANC $17.18
- AVG Volume (30 Days)
- IMVT 1.3M
- BANC 2.7M
- Earning Date
- IMVT 08-08-2025
- BANC 07-23-2025
- Dividend Yield
- IMVT N/A
- BANC 2.75%
- EPS Growth
- IMVT N/A
- BANC N/A
- EPS
- IMVT N/A
- BANC 0.64
- Revenue
- IMVT N/A
- BANC $949,659,000.00
- Revenue This Year
- IMVT N/A
- BANC $8.71
- Revenue Next Year
- IMVT N/A
- BANC $12.84
- P/E Ratio
- IMVT N/A
- BANC $22.53
- Revenue Growth
- IMVT N/A
- BANC 150.32
- 52 Week Low
- IMVT $12.72
- BANC $11.52
- 52 Week High
- IMVT $34.47
- BANC $18.08
- Technical
- Relative Strength Index (RSI)
- IMVT 41.15
- BANC 47.43
- Support Level
- IMVT $15.31
- BANC $14.88
- Resistance Level
- IMVT $17.12
- BANC $15.31
- Average True Range (ATR)
- IMVT 0.84
- BANC 0.41
- MACD
- IMVT -0.27
- BANC -0.05
- Stochastic Oscillator
- IMVT 20.53
- BANC 36.18
About IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The company operates in a single operating segment, which includes all activities related to the research, development and manufacturing of its product candidates.
About BANC Banc of California Inc.
Banc of California Inc is a financial holding company. It offers banking and financial services. Its services include banking services, lending services, and private banking services. Its deposit and banking product and service offerings include checking, savings, money market, certificates of deposit, and retirement accounts. Lending activities are focused on providing financing to California's diverse private businesses, entrepreneurs, and communities, and loans are often secured by California commercial and residential real estate. The company has one reportable segment named Commercial banking.